Tesofensine 99% High peptide content white powder GLP/GLP-1
TDS 80 Inquiries
195875-84-4
Pharmaceutical Grade
99%
GUANGZHOU
STTY
5 mg/vial, 10vial/kit;10 mg/vial,10vial/kit;15 mg/vial, 10vial/kit
2026-10-01
Peptide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceTesofensine ((1R, 2R, 3S, 5S)-3-(3, 4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane)) is an inhibitor of neuronal reuptake of dopamine, noradrenaline, and serotonin. Tesofensine was developed for the treatment of Alzheimer's and Parkinson's disease but lacked efficacy. Meta-analysis revealed that tesofensine (0.125–1.0 mg, once daily; oral) produced dose-dependent weight loss, and 32% of obese patients had ≥ 5% weight loss following 14 wk of treatment. Weight loss was accompanied by hypophagia, suggesting an appetite suppressant action[2].
Tesofensine is a dopamine, serotonin, and noradrenaline (triple) reuptake inhibitor originally developed by NeuroSearch for the treatment of Alzheimer's disease and Parkinson's disease. Development of the compound for these neurological indications was unsuccessful but significant weight loss was reported during the clinical trials in Parkinson's disease. Hence, tesofensine is now being developed by NeuroSearch for the treatment of obesity and type 2 diabetes[1].Research & Reference NoteTesofensine 99% High peptide content white powder GLP/GLP-1 is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Authoritative sourcesDisclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals
Certificates-
TDS
Basic Info-
Product Name:
tesofensine
Other Name:(1S,3S,4R,5R)-3-(3,4-dichlorophenyl)-4-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane;(1R,2R,3S,5S)-3-(3,4-Dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane;Tesofensine-13C-d3;8-Azabicyclo[3.2.1]octane, 3-(3,4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-, (1R,2R,3S,5S)-;Tesofensine 500mcg Tablets;Tesofensine 0.5mg Tablets
CAS No.:195875-84-4
Molecular Formula:C17H23Cl2NO
InChIKeys:VCVWXKKWDOJNIT-ZOMKSWQUSA-N
Molecular Weight:328.28
Exact Mass:328.28
UNII:BLH9UKX9V1
Color/Form:White to off-white
Categories:
Characteristics-
Density:
1.161±0.06 g/cm3(Predicted)
Boiling Point:396.6±42.0 °C(Predicted)
PKA:10.46±0.60(Predicted)
Critical Temperature & Pressure:Store at -20°C
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Peptide
-
Location:
Room 1501, Building 1, Changnan Mansion, Country Garden, on the west side of Taoyang North Road
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
11
-
Year of Establishment:
2025
-
-
Inquiry History80 Inquiries
Country Product Purchase Quantity Date Posted
United Kingdom
CAS: 195875-84-4
10 G Oct 25, 2025
Indonesia
High quality Tesofensine 500mcg cas 195875-84-4 100pcs/bottle
4 Apr 18, 2025
United States
High Purity Tesofensine Powder 99% White Powder CAS 195875-84-4 EGC-Tesofensine Powder
1 KG Oct 27, 2023
United States
Tesofensine
1 G May 30, 2026
United States
Tesofensine
10 G May 27, 2026
United Kingdom
Tesofensine
1 G May 16, 2026
United Kingdom
Tesofensine
1 G May 10, 2026
United Kingdom
Tesofensine
10 G Apr 20, 2026
United Kingdom
Tesofensine
100 PCS Apr 11, 2026
United States
Tesofensine
1 KG Mar 8, 2026
India
Tesofensine
10 MG Feb 22, 2026
United States
Tesofensine
20 G Feb 14, 2026
Thailand
High purity 99% Tesofensine white powder
500 MT Dec 12, 2025
France
Tesofensine
200 Nov 1, 2025
United States
Tesofensine
5 G Oct 8, 2025
Switzerland
tesofensine
1000 MT Sep 4, 2025
United States
tesofensine
1 KG Aug 4, 2025
United States
Tesofensine
10 G Jul 5, 2025
United States
Tesofensine
1 MT Apr 22, 2025
Germany
Tesofensine
1 KG Apr 17, 2025 Post an enquiry for this product